Materias dentro de su búsqueda.
Mostrando 1,101 - 1,120 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.51s Limitar resultados
  1. 1101
    “…In SKBR3 and BT474 breast cancer cell lines treated with anti-HER2 therapies, MAF1 mRNA expression is significantly increased. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MAF1 is a predictive biomarker in HER2 positive breast cancer
  2. 1102
    “…Aim: To evaluate the efficacy and safety of electroporation therapy treatment of vulvovaginal laxity by the Jett Plasma for Her II device. Methods: The Jett Plasma for Her II Study is a multicentric, prospective, randomized, single-blinded, and controlled study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment of Vulvovaginal Laxity by Electroporation: The Jett Plasma Medical for Her II Study
  3. 1103
    “…PURPOSE: Patients with human epidermal growth factor receptor 2 (HER2)–low advanced breast cancer can benefit from trastuzumab deruxtecan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
  4. 1104
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Driving the implementation of the National Health Act of Nigeria to improve the health of her population
  5. 1105
    “…In vitro, CCNE1 was overexpressed or knocked down in HER2+ cell lines to evaluate drug combination efficacy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
  6. 1106
    “…One such tumor surface receptor is human epidermal growth factor 2 (HER2), which is of interest for the treatment of many gynecologic tumors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
  7. 1107
    “…Background: This study aimed to investigate the effect of increased HER-2 expression on tumor-infiltrating lymphocytes (TILs) and determine its impact on the prognosis of colorectal cancer (CRC) patients; Methods: HER-2, CD4, CD8, CD19, LY6G, CD56, CD68, CD11b, and EpCam expression in CRC tissues and adjacent paracancerous tissues were assessed using multiplex fluorescence immunohistochemical staining. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration
  8. 1108
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    His unemployment, her response, and the moderating role of welfare policies in European countries
  9. 1109
    “…The aim of this study was to determine the basis for anti-tumor immune reactivity observed in patients with human epidermal growth factor receptor-2 (HER-2) (3+) breast carcinoma using an in vitro model in which the role of the HER-2-specific monoclonal antibody Herceptin was also investigated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    The antitumor immune response in HER-2 positive, metastatic breast cancer patients
  10. 1110
    por Miles, David W
    Publicado 2001
    “…Further analysis also implies that cases which are positive for HER-2 by fluorescent in situ hybridization may also benefit from treatment regardless of whether they express HER-2 at the 2+ or 3+ level. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
  11. 1111
    “…Although human epidermal growth factor receptor 2 (HER2) overexpression is implicated in tumor progression for a variety of cancer types, how it dysregulates signaling networks governing cell behavioral functions is poorly understood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Effects of HER2 overexpression on cell signaling networks governing proliferation and migration
  12. 1112
    “…INTRODUCTION: The status of the gene encoding human EGF-like receptor 2 (HER2) is an important prognostic and predictive marker in breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    HER2 gene status in primary breast cancers and matched distant metastases
  13. 1113
    “…To obtain more insight in the mechanism underlying the selective protective effects of monoHER, we investigated whether monoHER (1 mM) affects DOX-induced apoptosis in neonatal rat cardiac myocytes (NeRCaMs), human endothelial cells (HUVECs) and the ovarian cancer cell lines A2780 and OVCAR-3. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells
  14. 1114
    “…Since human epidermal growth factor receptor 2 (HER2) is known to participate with the epidermal growth factor receptor (EGFR) in mitogenic signalling, we hypothesised that HER2 overexpression might indicate responsiveness to EGFR targeted therapies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    HER2 expression as a potential marker for response to therapy targeted to the EGFR
  15. 1115
    “…It is well known that the amplification of the HER2 gene is closely associated with poor prognosis of breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Prognostic Significance of HER2 Gene Amplification According to Stage of Breast Cancer
  16. 1116
    “…Amplification of the HER-2 gene has been reported in lung cancer, where it has been associated with poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population
  17. 1117
    “…Gene amplification of HER-2 was observed in 2 of 26 patients with high HER-2 expression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
  18. 1118
    “…The aim of this study was to determine whether the hMena/hMena(11a) overexpression cooperates with HER-2 signalling, thereby affecting the HER2 mitogenic activity in breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
  19. 1119
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Pityriasis Rosea in a Woman and Her Husband – Case Report and Review of the Literature
  20. 1120
    “…RESULTS: Overall, we found only 5% HER2 high level amplification and 3% HER2 3+ overexpression (6/199). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Low frequency of HER2 amplification and overexpression in early onset gastric cancer
Herramientas de búsqueda: RSS